

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.68439745 |
| 2 | NIK/NF-kappaB signaling (GO:0038061) | 4.70390817 |
| 3 | proteasome assembly (GO:0043248) | 4.67034587 |
| 4 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.33194306 |
| 5 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.25070745 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 4.20273331 |
| 7 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.13824439 |
| 8 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.05765467 |
| 9 | rRNA modification (GO:0000154) | 4.00483996 |
| 10 | DNA replication checkpoint (GO:0000076) | 3.90624230 |
| 11 | ribosome biogenesis (GO:0042254) | 3.87640945 |
| 12 | termination of RNA polymerase III transcription (GO:0006386) | 3.85332348 |
| 13 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.85332348 |
| 14 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.79079320 |
| 15 | telomere maintenance via recombination (GO:0000722) | 3.69290885 |
| 16 | DNA strand elongation (GO:0022616) | 3.66266782 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 3.65475892 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 3.65475892 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.65475892 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.65475892 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.65475892 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.65475892 |
| 23 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.60411804 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 3.59092540 |
| 25 | pseudouridine synthesis (GO:0001522) | 3.56332795 |
| 26 | viral mRNA export from host cell nucleus (GO:0046784) | 3.55785190 |
| 27 | cullin deneddylation (GO:0010388) | 3.54771339 |
| 28 | DNA replication initiation (GO:0006270) | 3.52720085 |
| 29 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.50643711 |
| 30 | response to peptidoglycan (GO:0032494) | 3.45686586 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.45549188 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.45195504 |
| 33 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.40049015 |
| 34 | mitotic recombination (GO:0006312) | 3.40002568 |
| 35 | protein deneddylation (GO:0000338) | 3.38192487 |
| 36 | rRNA methylation (GO:0031167) | 3.31338747 |
| 37 | negative regulation of cell killing (GO:0031342) | 3.30526038 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.30526038 |
| 39 | actin nucleation (GO:0045010) | 3.24113112 |
| 40 | 7-methylguanosine mRNA capping (GO:0006370) | 3.23636131 |
| 41 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.22964426 |
| 42 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.22831784 |
| 43 | protein localization to kinetochore (GO:0034501) | 3.22811755 |
| 44 | mitotic metaphase plate congression (GO:0007080) | 3.22310992 |
| 45 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.21829855 |
| 46 | ribosomal small subunit biogenesis (GO:0042274) | 3.21304806 |
| 47 | telomere maintenance via telomere lengthening (GO:0010833) | 3.20445185 |
| 48 | 7-methylguanosine RNA capping (GO:0009452) | 3.18838091 |
| 49 | RNA capping (GO:0036260) | 3.18838091 |
| 50 | maturation of SSU-rRNA (GO:0030490) | 3.18719613 |
| 51 | DNA damage response, detection of DNA damage (GO:0042769) | 3.17587739 |
| 52 | formation of translation preinitiation complex (GO:0001731) | 3.17030872 |
| 53 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.16963042 |
| 54 | spliceosomal snRNP assembly (GO:0000387) | 3.15779407 |
| 55 | replication fork processing (GO:0031297) | 3.13899364 |
| 56 | transcription from RNA polymerase I promoter (GO:0006360) | 3.11422092 |
| 57 | kinetochore assembly (GO:0051382) | 3.10737808 |
| 58 | negative regulation of telomere maintenance (GO:0032205) | 3.09973245 |
| 59 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.09872954 |
| 60 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.08518810 |
| 61 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.08456753 |
| 62 | negative regulation of interleukin-12 production (GO:0032695) | 3.07992730 |
| 63 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.07922026 |
| 64 | histone H4-K12 acetylation (GO:0043983) | 3.06865223 |
| 65 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.06531317 |
| 66 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.06531317 |
| 67 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.06531317 |
| 68 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.05770592 |
| 69 | cellular response to type I interferon (GO:0071357) | 3.05344396 |
| 70 | type I interferon signaling pathway (GO:0060337) | 3.05344396 |
| 71 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05176138 |
| 72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.03756062 |
| 73 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.03522353 |
| 74 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.02061832 |
| 75 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.02061832 |
| 76 | response to type I interferon (GO:0034340) | 3.00484845 |
| 77 | ribosomal large subunit biogenesis (GO:0042273) | 2.99585548 |
| 78 | mitotic sister chromatid segregation (GO:0000070) | 2.99456144 |
| 79 | polyketide metabolic process (GO:0030638) | 2.99281180 |
| 80 | doxorubicin metabolic process (GO:0044598) | 2.99281180 |
| 81 | daunorubicin metabolic process (GO:0044597) | 2.99281180 |
| 82 | GDP-mannose metabolic process (GO:0019673) | 2.99079028 |
| 83 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.97755094 |
| 84 | COPI coating of Golgi vesicle (GO:0048205) | 2.97713804 |
| 85 | Golgi transport vesicle coating (GO:0048200) | 2.97713804 |
| 86 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.97423172 |
| 87 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.97423172 |
| 88 | cellular response to virus (GO:0098586) | 2.96712959 |
| 89 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.95917427 |
| 90 | rRNA processing (GO:0006364) | 2.95495290 |
| 91 | neutrophil activation involved in immune response (GO:0002283) | 2.94917430 |
| 92 | nucleobase biosynthetic process (GO:0046112) | 2.94294266 |
| 93 | protein localization to endosome (GO:0036010) | 2.93802264 |
| 94 | purine nucleobase biosynthetic process (GO:0009113) | 2.93776055 |
| 95 | respiratory burst (GO:0045730) | 2.93656436 |
| 96 | detection of bacterium (GO:0016045) | 2.92979849 |
| 97 | myeloid dendritic cell differentiation (GO:0043011) | 2.90678578 |
| 98 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.89152658 |
| 99 | modulation by symbiont of host cellular process (GO:0044068) | 2.88978801 |
| 100 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.88580189 |
| 101 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.88357806 |
| 102 | negative regulation of ligase activity (GO:0051352) | 2.88087332 |
| 103 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.88087332 |
| 104 | maturation of 5.8S rRNA (GO:0000460) | 2.87936582 |
| 105 | barbed-end actin filament capping (GO:0051016) | 2.86477198 |
| 106 | modulation by virus of host process (GO:0019054) | 2.85417716 |
| 107 | cellular component biogenesis (GO:0044085) | 2.83196673 |
| 108 | rRNA metabolic process (GO:0016072) | 2.82973355 |
| 109 | * regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.82726335 |
| 110 | viral protein processing (GO:0019082) | 2.81453666 |
| 111 | detection of other organism (GO:0098543) | 2.81065190 |
| 112 | macrophage activation involved in immune response (GO:0002281) | 2.80445643 |
| 113 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.80370135 |
| 114 | protein localization to chromosome, centromeric region (GO:0071459) | 2.80314515 |
| 115 | regulation of superoxide anion generation (GO:0032928) | 2.79085631 |
| 116 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.79037488 |
| 117 | negative regulation of B cell apoptotic process (GO:0002903) | 2.77020320 |
| 118 | CENP-A containing nucleosome assembly (GO:0034080) | 2.76394918 |
| 119 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.75540624 |
| 120 | kinetochore organization (GO:0051383) | 2.75264813 |
| 121 | activation of MAPKKK activity (GO:0000185) | 2.75203598 |
| 122 | amino sugar catabolic process (GO:0046348) | 2.75127552 |
| 123 | tRNA methylation (GO:0030488) | 2.74432262 |
| 124 | sequestering of actin monomers (GO:0042989) | 2.73958999 |
| 125 | transcription from mitochondrial promoter (GO:0006390) | 2.72277624 |
| 126 | DNA-dependent DNA replication (GO:0006261) | 2.72209821 |
| 127 | virion assembly (GO:0019068) | 2.71748023 |
| 128 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.70509254 |
| 129 | regulation of defense response to virus by virus (GO:0050690) | 2.70463195 |
| 130 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.70381563 |
| 131 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.70283857 |
| 132 | protein maturation by protein folding (GO:0022417) | 2.68403275 |
| 133 | pyrimidine-containing compound salvage (GO:0008655) | 2.68077066 |
| 134 | pyrimidine nucleoside salvage (GO:0043097) | 2.68077066 |
| 135 | viral transcription (GO:0019083) | 2.67955745 |
| 136 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.67905789 |
| 137 | spliceosomal complex assembly (GO:0000245) | 2.67718256 |
| 138 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.66536402 |
| 139 | cell cycle G1/S phase transition (GO:0044843) | 2.66536402 |
| 140 | tRNA modification (GO:0006400) | 2.66318650 |
| 141 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.66312400 |
| 142 | regulation of mast cell degranulation (GO:0043304) | 2.65601481 |
| 143 | amyloid precursor protein catabolic process (GO:0042987) | 2.65021267 |
| 144 | histone arginine methylation (GO:0034969) | 2.64493954 |
| 145 | chromatin remodeling at centromere (GO:0031055) | 2.63030100 |
| 146 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 2.62746187 |
| 147 | GMP metabolic process (GO:0046037) | 2.62377838 |
| 148 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.61336152 |
| 149 | RNA methylation (GO:0001510) | 2.60978093 |
| 150 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.60965440 |
| 151 | response to muramyl dipeptide (GO:0032495) | 2.60783250 |
| 152 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.60709083 |
| 153 | positive regulation of cell cycle arrest (GO:0071158) | 2.59568305 |
| 154 | nuclear envelope reassembly (GO:0031468) | 2.59350595 |
| 155 | mitotic nuclear envelope reassembly (GO:0007084) | 2.59350595 |
| 156 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.59262044 |
| 157 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.59213891 |
| 158 | DNA ligation (GO:0006266) | 2.58924177 |
| 159 | mannose metabolic process (GO:0006013) | 2.58750774 |
| 160 | positive regulation of viral transcription (GO:0050434) | 2.58565231 |
| 161 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.56805694 |
| 162 | metaphase plate congression (GO:0051310) | 2.56622718 |
| 163 | translation (GO:0006412) | 2.56444462 |
| 164 | regulation of leukocyte degranulation (GO:0043300) | 2.56166588 |
| 165 | protein insertion into membrane (GO:0051205) | 2.54782520 |
| 166 | myeloid dendritic cell activation (GO:0001773) | 2.54630756 |
| 167 | protein retention in ER lumen (GO:0006621) | 2.52782826 |
| 168 | apoptotic process involved in morphogenesis (GO:0060561) | 2.51537673 |
| 169 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.51405276 |
| 170 | pentose-phosphate shunt (GO:0006098) | 2.46405090 |
| 171 | B cell mediated immunity (GO:0019724) | 2.46244133 |
| 172 | granulocyte activation (GO:0036230) | 2.45020711 |
| 173 | UV protection (GO:0009650) | 2.45019084 |
| 174 | regulation of cellular extravasation (GO:0002691) | 2.44508684 |
| 175 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.44479050 |
| 176 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.43898902 |
| 177 | positive thymic T cell selection (GO:0045059) | 2.42788069 |
| 178 | negative regulation of innate immune response (GO:0045824) | 2.41676450 |
| 179 | T cell migration (GO:0072678) | 2.41638883 |
| 180 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.39691871 |
| 181 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.37290390 |
| 182 | regulation of necrotic cell death (GO:0010939) | 2.37203561 |
| 183 | response to host immune response (GO:0052572) | 2.36342675 |
| 184 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.36342675 |
| 185 | regulation of protein heterodimerization activity (GO:0043497) | 2.36329091 |
| 186 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.35185097 |
| 187 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.34830013 |
| 188 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.34003519 |
| 189 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.33833183 |
| 190 | leukocyte aggregation (GO:0070486) | 2.33199971 |
| 191 | response to protozoan (GO:0001562) | 2.32968575 |
| 192 | positive regulation of T cell apoptotic process (GO:0070234) | 2.32827259 |
| 193 | glycosphingolipid catabolic process (GO:0046479) | 2.31952782 |
| 194 | regulation of B cell apoptotic process (GO:0002902) | 2.31481963 |
| 195 | metallo-sulfur cluster assembly (GO:0031163) | 2.31424722 |
| 196 | iron-sulfur cluster assembly (GO:0016226) | 2.31424722 |
| 197 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.31360100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.45501347 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.83088125 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.53758970 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.49144461 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.35645866 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.21091422 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.05524034 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.00281369 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.97370785 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.92483828 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.85218844 |
| 12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.77962293 |
| 13 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.75614037 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.72313546 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.66157151 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.64532306 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.58923038 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.54712515 |
| 19 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.53030250 |
| 20 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.35975124 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34544538 |
| 22 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.32449335 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.31169769 |
| 24 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.27114744 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.25701986 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.24209556 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22971668 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.22168163 |
| 29 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.19571589 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.13121160 |
| 31 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.10220331 |
| 32 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.05572874 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.02835578 |
| 34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.02622093 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.00442545 |
| 36 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.00292825 |
| 37 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.95193144 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93574078 |
| 39 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.90909471 |
| 40 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.90909471 |
| 41 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.90909471 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90541044 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.90208812 |
| 44 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.89983660 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89578743 |
| 46 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85388818 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.83781903 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83567246 |
| 49 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.83434928 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82469713 |
| 51 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.81852117 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.81328146 |
| 53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.81220525 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.76333009 |
| 55 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.75974872 |
| 56 | P68_20966046_ChIP-Seq_HELA_Human | 1.74529034 |
| 57 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.72051904 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.71464742 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.68932834 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.68818880 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67508641 |
| 62 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.66382932 |
| 63 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.66325318 |
| 64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65537585 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64715832 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.64612238 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.63952138 |
| 68 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.62698910 |
| 69 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.62470514 |
| 70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.58782781 |
| 71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.58410102 |
| 72 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.56742944 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.55865025 |
| 74 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.55077291 |
| 75 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.54307636 |
| 76 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54134663 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53063834 |
| 78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50351379 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.50234293 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49087212 |
| 81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48508934 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48472140 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48154341 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46189016 |
| 85 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.46164117 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45327199 |
| 87 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.42918470 |
| 88 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.42905672 |
| 89 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42550188 |
| 90 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40792387 |
| 91 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.40148560 |
| 92 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.38929353 |
| 93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38789558 |
| 94 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38610253 |
| 95 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.38524669 |
| 96 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37727363 |
| 97 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.37670086 |
| 98 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.36659810 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.35870923 |
| 100 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.35377348 |
| 101 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.35074512 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34469804 |
| 103 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.34269922 |
| 104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34035839 |
| 105 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.33187886 |
| 106 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30937231 |
| 107 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.30116164 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28948969 |
| 109 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.26105554 |
| 110 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25495082 |
| 111 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25493121 |
| 112 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25329666 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24827409 |
| 114 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23350817 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23172712 |
| 116 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.22254679 |
| 117 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20971990 |
| 118 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20457565 |
| 119 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.20283727 |
| 120 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19653055 |
| 121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18445728 |
| 122 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.17698765 |
| 123 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16589740 |
| 124 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15523899 |
| 125 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15276138 |
| 126 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.14839647 |
| 127 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14675343 |
| 128 | MYC_22102868_ChIP-Seq_BL_Human | 1.14670579 |
| 129 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14234775 |
| 130 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.14201402 |
| 131 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14072548 |
| 132 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13523162 |
| 133 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.13372879 |
| 134 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11325144 |
| 135 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.10566739 |
| 136 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10516803 |
| 137 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.09982050 |
| 138 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08923670 |
| 139 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08772424 |
| 140 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.08670632 |
| 141 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.08641742 |
| 142 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08456807 |
| 143 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08423880 |
| 144 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07799925 |
| 145 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07222950 |
| 146 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.07034365 |
| 147 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.06616683 |
| 148 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06614865 |
| 149 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04771110 |
| 150 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04528733 |
| 151 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03460682 |
| 152 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02896261 |
| 153 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.02461849 |
| 154 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02406314 |
| 155 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.01686192 |
| 156 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.01402163 |
| 157 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01077510 |
| 158 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00760003 |
| 159 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.99483311 |
| 160 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98065105 |
| 161 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.96374085 |
| 162 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.96258299 |
| 163 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.95130339 |
| 164 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94441768 |
| 165 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.92101720 |
| 166 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.91961111 |
| 167 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89404083 |
| 168 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88549822 |
| 169 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.88226096 |
| 170 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86307745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.84196799 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.82344258 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.75415755 |
| 4 | MP0003303_peritoneal_inflammation | 3.57477593 |
| 5 | MP0006292_abnormal_olfactory_placode | 3.49632859 |
| 6 | MP0008057_abnormal_DNA_replication | 3.03590814 |
| 7 | MP0009278_abnormal_bone_marrow | 2.97179080 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.96390806 |
| 9 | MP0009840_abnormal_foam_cell | 2.94702027 |
| 10 | MP0005451_abnormal_body_composition | 2.94332205 |
| 11 | MP0008058_abnormal_DNA_repair | 2.85994007 |
| 12 | MP0003111_abnormal_nucleus_morphology | 2.77074376 |
| 13 | * MP0010094_abnormal_chromosome_stability | 2.73894829 |
| 14 | MP0003077_abnormal_cell_cycle | 2.61465365 |
| 15 | MP0005025_abnormal_response_to | 2.55668876 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.46997242 |
| 17 | MP0005075_abnormal_melanosome_morpholog | 2.37107650 |
| 18 | MP0002653_abnormal_ependyma_morphology | 2.34654643 |
| 19 | MP0001790_abnormal_immune_system | 2.33656866 |
| 20 | MP0005387_immune_system_phenotype | 2.33656866 |
| 21 | MP0002419_abnormal_innate_immunity | 2.31902129 |
| 22 | MP0003724_increased_susceptibility_to | 2.29164686 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.27623388 |
| 24 | MP0000685_abnormal_immune_system | 2.23284408 |
| 25 | MP0008789_abnormal_olfactory_epithelium | 2.22353054 |
| 26 | MP0006082_CNS_inflammation | 2.21321079 |
| 27 | MP0003172_abnormal_lysosome_physiology | 2.20195473 |
| 28 | MP0005499_abnormal_olfactory_system | 2.16534235 |
| 29 | MP0005394_taste/olfaction_phenotype | 2.16534235 |
| 30 | MP0008932_abnormal_embryonic_tissue | 2.12674089 |
| 31 | MP0001800_abnormal_humoral_immune | 2.09430034 |
| 32 | MP0002723_abnormal_immune_serum | 2.06308654 |
| 33 | MP0002452_abnormal_antigen_presenting | 2.04521508 |
| 34 | MP0003136_yellow_coat_color | 2.02938165 |
| 35 | MP0002132_abnormal_respiratory_system | 2.02387356 |
| 36 | MP0000015_abnormal_ear_pigmentation | 2.01113474 |
| 37 | * MP0008007_abnormal_cellular_replicative | 2.00578358 |
| 38 | MP0004947_skin_inflammation | 1.94918262 |
| 39 | MP0003315_abnormal_perineum_morphology | 1.85654826 |
| 40 | MP0003718_maternal_effect | 1.83267905 |
| 41 | MP0001188_hyperpigmentation | 1.82758065 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.81388301 |
| 43 | MP0000490_abnormal_crypts_of | 1.79839200 |
| 44 | MP0000049_abnormal_middle_ear | 1.73225461 |
| 45 | MP0004510_myositis | 1.72970818 |
| 46 | MP0000604_amyloidosis | 1.71343002 |
| 47 | * MP0003786_premature_aging | 1.70804230 |
| 48 | MP0002751_abnormal_autonomic_nervous | 1.68183030 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.64647716 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.64085575 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.63422501 |
| 52 | MP0003075_altered_response_to | 1.62141728 |
| 53 | MP0003329_amyloid_beta_deposits | 1.61425141 |
| 54 | * MP0001845_abnormal_inflammatory_respons | 1.58278747 |
| 55 | MP0002160_abnormal_reproductive_system | 1.57840196 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.56679080 |
| 57 | MP0004858_abnormal_nervous_system | 1.55892870 |
| 58 | MP0009764_decreased_sensitivity_to | 1.55261816 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.52393581 |
| 60 | * MP0010155_abnormal_intestine_physiology | 1.51045476 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.45990776 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.45960114 |
| 63 | MP0010030_abnormal_orbit_morphology | 1.44536031 |
| 64 | MP0001873_stomach_inflammation | 1.42792109 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.42715795 |
| 66 | MP0008469_abnormal_protein_level | 1.42655042 |
| 67 | * MP0000350_abnormal_cell_proliferation | 1.40613386 |
| 68 | MP0000343_altered_response_to | 1.40233414 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.36439022 |
| 70 | MP0005671_abnormal_response_to | 1.35807478 |
| 71 | MP0002009_preneoplasia | 1.28496328 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.27409134 |
| 73 | * MP0000313_abnormal_cell_death | 1.26876743 |
| 74 | MP0001849_ear_inflammation | 1.26791629 |
| 75 | MP0003938_abnormal_ear_development | 1.26719571 |
| 76 | MP0001293_anophthalmia | 1.25918883 |
| 77 | MP0000372_irregular_coat_pigmentation | 1.24554896 |
| 78 | MP0002254_reproductive_system_inflammat | 1.24304058 |
| 79 | MP0003941_abnormal_skin_development | 1.24243085 |
| 80 | MP0001919_abnormal_reproductive_system | 1.24038433 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 1.23188888 |
| 82 | MP0003866_abnormal_defecation | 1.23015287 |
| 83 | MP0009379_abnormal_foot_pigmentation | 1.22733337 |
| 84 | MP0001835_abnormal_antigen_presentation | 1.21923737 |
| 85 | MP0008877_abnormal_DNA_methylation | 1.20783021 |
| 86 | MP0002163_abnormal_gland_morphology | 1.19810847 |
| 87 | MP0003123_paternal_imprinting | 1.19514801 |
| 88 | MP0005389_reproductive_system_phenotype | 1.18242616 |
| 89 | MP0003121_genomic_imprinting | 1.17008396 |
| 90 | MP0001853_heart_inflammation | 1.16353032 |
| 91 | MP0005310_abnormal_salivary_gland | 1.14264093 |
| 92 | MP0002095_abnormal_skin_pigmentation | 1.13818332 |
| 93 | MP0002998_abnormal_bone_remodeling | 1.12332570 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 1.11013441 |
| 95 | MP0001672_abnormal_embryogenesis/_devel | 1.10785815 |
| 96 | MP0005380_embryogenesis_phenotype | 1.10785815 |
| 97 | MP0009785_altered_susceptibility_to | 1.09988156 |
| 98 | MP0008260_abnormal_autophagy | 1.09153587 |
| 99 | MP0001663_abnormal_digestive_system | 1.08170424 |
| 100 | MP0001119_abnormal_female_reproductive | 1.07795420 |
| 101 | MP0003705_abnormal_hypodermis_morpholog | 1.06143598 |
| 102 | MP0001542_abnormal_bone_strength | 1.05588098 |
| 103 | MP0005166_decreased_susceptibility_to | 1.04754372 |
| 104 | MP0002019_abnormal_tumor_incidence | 1.04169278 |
| 105 | MP0002210_abnormal_sex_determination | 1.01731265 |
| 106 | * MP0002398_abnormal_bone_marrow | 1.00882204 |
| 107 | MP0003119_abnormal_digestive_system | 1.00688556 |
| 108 | MP0002085_abnormal_embryonic_tissue | 1.00150821 |
| 109 | MP0002938_white_spotting | 1.00104196 |
| 110 | MP0004133_heterotaxia | 0.99398142 |
| 111 | MP0000858_altered_metastatic_potential | 0.98471333 |
| 112 | MP0005397_hematopoietic_system_phenotyp | 0.97940428 |
| 113 | MP0001545_abnormal_hematopoietic_system | 0.97940428 |
| 114 | MP0001727_abnormal_embryo_implantation | 0.97493531 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.97458309 |
| 116 | MP0002933_joint_inflammation | 0.96297156 |
| 117 | MP0003567_abnormal_fetal_cardiomyocyte | 0.96053027 |
| 118 | MP0000750_abnormal_muscle_regeneration | 0.95499965 |
| 119 | MP0002638_abnormal_pupillary_reflex | 0.95084440 |
| 120 | MP0004381_abnormal_hair_follicle | 0.93577309 |
| 121 | MP0005390_skeleton_phenotype | 0.93294272 |
| 122 | MP0002148_abnormal_hypersensitivity_rea | 0.92993268 |
| 123 | * MP0000689_abnormal_spleen_morphology | 0.92107220 |
| 124 | * MP0002722_abnormal_immune_system | 0.90831583 |
| 125 | MP0002249_abnormal_larynx_morphology | 0.90546678 |
| 126 | MP0003448_altered_tumor_morphology | 0.90486509 |
| 127 | MP0001697_abnormal_embryo_size | 0.90412654 |
| 128 | MP0008995_early_reproductive_senescence | 0.90248241 |
| 129 | MP0001730_embryonic_growth_arrest | 0.89613557 |
| 130 | MP0001186_pigmentation_phenotype | 0.89490652 |
| 131 | MP0003984_embryonic_growth_retardation | 0.89332703 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.89263537 |
| 133 | MP0002088_abnormal_embryonic_growth/wei | 0.87067782 |
| 134 | MP0002080_prenatal_lethality | 0.86640003 |
| 135 | MP0002177_abnormal_outer_ear | 0.86393853 |
| 136 | MP0000566_synostosis | 0.86319704 |
| 137 | MP0005171_absent_coat_pigmentation | 0.85194978 |
| 138 | MP0003890_abnormal_embryonic-extraembry | 0.85120528 |
| 139 | MP0002139_abnormal_hepatobiliary_system | 0.83654509 |
| 140 | MP0000703_abnormal_thymus_morphology | 0.83444441 |
| 141 | MP0008874_decreased_physiological_sensi | 0.83195633 |
| 142 | MP0001348_abnormal_lacrimal_gland | 0.82298343 |
| 143 | * MP0002429_abnormal_blood_cell | 0.81352136 |
| 144 | MP0004808_abnormal_hematopoietic_stem | 0.81194539 |
| 145 | MP0005257_abnormal_intraocular_pressure | 0.80915476 |
| 146 | MP0000516_abnormal_urinary_system | 0.80162447 |
| 147 | MP0005367_renal/urinary_system_phenotyp | 0.80162447 |
| 148 | MP0005381_digestive/alimentary_phenotyp | 0.79674169 |
| 149 | MP0001286_abnormal_eye_development | 0.79636880 |
| 150 | MP0005076_abnormal_cell_differentiation | 0.79105162 |
| 151 | * MP0000716_abnormal_immune_system | 0.78692479 |
| 152 | MP0002405_respiratory_system_inflammati | 0.77354017 |
| 153 | MP0002075_abnormal_coat/hair_pigmentati | 0.77292481 |
| 154 | MP0006054_spinal_hemorrhage | 0.76917258 |
| 155 | MP0002420_abnormal_adaptive_immunity | 0.76735806 |
| 156 | MP0001819_abnormal_immune_cell | 0.76431889 |
| 157 | MP0003186_abnormal_redox_activity | 0.76223795 |
| 158 | MP0003122_maternal_imprinting | 0.74218089 |
| 159 | MP0001145_abnormal_male_reproductive | 0.73140763 |
| 160 | MP0009763_increased_sensitivity_to | 0.72528771 |
| 161 | MP0002138_abnormal_hepatobiliary_system | 0.71486086 |
| 162 | * MP0003795_abnormal_bone_structure | 0.69393365 |
| 163 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69038397 |
| 164 | MP0000358_abnormal_cell_content/ | 0.68998082 |
| 165 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66617569 |
| 166 | MP0002877_abnormal_melanocyte_morpholog | 0.66153436 |
| 167 | MP0002332_abnormal_exercise_endurance | 0.65724127 |
| 168 | MP0005319_abnormal_enzyme/_coenzyme | 0.64941851 |
| 169 | MP0005501_abnormal_skin_physiology | 0.64511545 |
| 170 | MP0004185_abnormal_adipocyte_glucose | 0.63306268 |
| 171 | MP0009931_abnormal_skin_appearance | 0.62910182 |
| 172 | MP0003279_aneurysm | 0.60507467 |
| 173 | * MP0000609_abnormal_liver_physiology | 0.59239485 |
| 174 | MP0001216_abnormal_epidermal_layer | 0.59126744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.10591529 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.10591529 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.10591529 |
| 4 | Type I transferrin isoform profile (HP:0003642) | 3.94791977 |
| 5 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.91537320 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.88273975 |
| 7 | Birth length less than 3rd percentile (HP:0003561) | 3.78420573 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.73264033 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.61267810 |
| 10 | Chromsome breakage (HP:0040012) | 3.41304734 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.40443526 |
| 12 | Breast hypoplasia (HP:0003187) | 3.35081673 |
| 13 | Meckel diverticulum (HP:0002245) | 3.34832688 |
| 14 | Dysostosis multiplex (HP:0000943) | 3.30474581 |
| 15 | Abnormality of the ileum (HP:0001549) | 3.29294250 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.29187120 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.29108374 |
| 18 | Obstructive lung disease (HP:0006536) | 3.29108374 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.25918849 |
| 20 | Loss of speech (HP:0002371) | 3.23332766 |
| 21 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.21484398 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.17355418 |
| 23 | Patellar aplasia (HP:0006443) | 3.16586394 |
| 24 | Abnormality of the anterior horn cell (HP:0006802) | 3.15621814 |
| 25 | Degeneration of anterior horn cells (HP:0002398) | 3.15621814 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.11484961 |
| 27 | Abnormal number of erythroid precursors (HP:0012131) | 3.06663077 |
| 28 | Impulsivity (HP:0100710) | 3.01471996 |
| 29 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.99335696 |
| 30 | Rectal fistula (HP:0100590) | 2.98270513 |
| 31 | Rectovaginal fistula (HP:0000143) | 2.98270513 |
| 32 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.95784041 |
| 33 | Aplastic anemia (HP:0001915) | 2.93975443 |
| 34 | Intestinal fistula (HP:0100819) | 2.91832703 |
| 35 | Increased IgE level (HP:0003212) | 2.90482913 |
| 36 | Reduced antithrombin III activity (HP:0001976) | 2.90080682 |
| 37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.89960392 |
| 38 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.87757762 |
| 39 | Ragged-red muscle fibers (HP:0003200) | 2.86006900 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.85423712 |
| 41 | Abnormality of the preputium (HP:0100587) | 2.83652721 |
| 42 | Cellulitis (HP:0100658) | 2.81976199 |
| 43 | Hypertensive crisis (HP:0100735) | 2.80174838 |
| 44 | Type 2 muscle fiber atrophy (HP:0003554) | 2.77321693 |
| 45 | Absent thumb (HP:0009777) | 2.76800534 |
| 46 | Myositis (HP:0100614) | 2.76455988 |
| 47 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.72040346 |
| 48 | Muscle fiber atrophy (HP:0100295) | 2.71487844 |
| 49 | Reticulocytopenia (HP:0001896) | 2.69121243 |
| 50 | Tongue fasciculations (HP:0001308) | 2.63116249 |
| 51 | Supernumerary spleens (HP:0009799) | 2.62030577 |
| 52 | Abnormal gallbladder physiology (HP:0012438) | 2.60885013 |
| 53 | Cholecystitis (HP:0001082) | 2.60885013 |
| 54 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.60599854 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.59551307 |
| 56 | Vertebral compression fractures (HP:0002953) | 2.58657553 |
| 57 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.53574043 |
| 58 | Rib fusion (HP:0000902) | 2.49395816 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.49189520 |
| 60 | Microretrognathia (HP:0000308) | 2.46611621 |
| 61 | Abnormal lung lobation (HP:0002101) | 2.46018156 |
| 62 | Petechiae (HP:0000967) | 2.43718544 |
| 63 | Microvesicular hepatic steatosis (HP:0001414) | 2.43035813 |
| 64 | Increased serum ferritin (HP:0003281) | 2.42731529 |
| 65 | Bone marrow hypocellularity (HP:0005528) | 2.41716381 |
| 66 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.40720719 |
| 67 | 3-Methylglutaconic aciduria (HP:0003535) | 2.40125866 |
| 68 | Vaginal fistula (HP:0004320) | 2.40091736 |
| 69 | Hypoplasia of the fovea (HP:0007750) | 2.38949460 |
| 70 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.38949460 |
| 71 | Urticaria (HP:0001025) | 2.38900606 |
| 72 | Neuronal loss in central nervous system (HP:0002529) | 2.37938236 |
| 73 | Meningitis (HP:0001287) | 2.37669364 |
| 74 | Triphalangeal thumb (HP:0001199) | 2.36042535 |
| 75 | Abnormal protein glycosylation (HP:0012346) | 2.36034399 |
| 76 | Abnormal glycosylation (HP:0012345) | 2.36034399 |
| 77 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.36034399 |
| 78 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.36034399 |
| 79 | Recurrent fungal infections (HP:0002841) | 2.35031935 |
| 80 | Orchitis (HP:0100796) | 2.33944129 |
| 81 | Prolonged neonatal jaundice (HP:0006579) | 2.33580065 |
| 82 | Mutism (HP:0002300) | 2.33143067 |
| 83 | Axonal loss (HP:0003447) | 2.28203182 |
| 84 | Embryonal renal neoplasm (HP:0011794) | 2.27386158 |
| 85 | Increased IgM level (HP:0003496) | 2.26776958 |
| 86 | Progressive neurologic deterioration (HP:0002344) | 2.26362998 |
| 87 | Duodenal stenosis (HP:0100867) | 2.25987770 |
| 88 | Small intestinal stenosis (HP:0012848) | 2.25987770 |
| 89 | Cleft eyelid (HP:0000625) | 2.24266383 |
| 90 | Clubbing of toes (HP:0100760) | 2.24124304 |
| 91 | Recurrent viral infections (HP:0004429) | 2.23599345 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.22613747 |
| 93 | Absent radius (HP:0003974) | 2.21837040 |
| 94 | Abnormality of chromosome stability (HP:0003220) | 2.21231345 |
| 95 | Diminished motivation (HP:0000745) | 2.19945559 |
| 96 | Autoimmune thrombocytopenia (HP:0001973) | 2.19833727 |
| 97 | Carpal bone hypoplasia (HP:0001498) | 2.18600786 |
| 98 | Rough bone trabeculation (HP:0100670) | 2.18220074 |
| 99 | Myelodysplasia (HP:0002863) | 2.18123546 |
| 100 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17224070 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17224070 |
| 102 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17224070 |
| 103 | Muscle fibrillation (HP:0010546) | 2.16269704 |
| 104 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13444508 |
| 105 | J-shaped sella turcica (HP:0002680) | 2.13039860 |
| 106 | Stomatitis (HP:0010280) | 2.12438956 |
| 107 | Gastrointestinal stroma tumor (HP:0100723) | 2.11059798 |
| 108 | Purpura (HP:0000979) | 2.10927141 |
| 109 | Thin bony cortex (HP:0002753) | 2.10179082 |
| 110 | Premature graying of hair (HP:0002216) | 2.09279334 |
| 111 | Gastrointestinal inflammation (HP:0004386) | 2.08227948 |
| 112 | Apathy (HP:0000741) | 2.06898894 |
| 113 | Premature loss of primary teeth (HP:0006323) | 2.06646416 |
| 114 | Aplasia involving forearm bones (HP:0009822) | 2.06511146 |
| 115 | Absent forearm bone (HP:0003953) | 2.06511146 |
| 116 | Distal upper limb amyotrophy (HP:0007149) | 2.06460614 |
| 117 | Upper limb amyotrophy (HP:0009129) | 2.06460614 |
| 118 | Optic nerve coloboma (HP:0000588) | 2.04449702 |
| 119 | Hypoplasia of the radius (HP:0002984) | 2.03501193 |
| 120 | Agammaglobulinemia (HP:0004432) | 2.03261161 |
| 121 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.03150813 |
| 122 | Progressive muscle weakness (HP:0003323) | 2.02723966 |
| 123 | Cerebral hypomyelination (HP:0006808) | 2.02469061 |
| 124 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.02328137 |
| 125 | Nuclear cataract (HP:0100018) | 2.01819046 |
| 126 | Growth hormone excess (HP:0000845) | 2.00329597 |
| 127 | Recurrent skin infections (HP:0001581) | 2.00240494 |
| 128 | Hyperparathyroidism (HP:0000843) | 1.99508547 |
| 129 | Amyloidosis (HP:0011034) | 1.98141912 |
| 130 | Gingivitis (HP:0000230) | 1.97673567 |
| 131 | Gastrointestinal infarctions (HP:0005244) | 1.97589736 |
| 132 | Upper motor neuron abnormality (HP:0002127) | 1.97175722 |
| 133 | Tracheoesophageal fistula (HP:0002575) | 1.96749712 |
| 134 | Sepsis (HP:0100806) | 1.96527278 |
| 135 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95782729 |
| 136 | Mucopolysacchariduria (HP:0008155) | 1.95782729 |
| 137 | Achilles tendon contracture (HP:0001771) | 1.95467913 |
| 138 | Pustule (HP:0200039) | 1.95134353 |
| 139 | Supranuclear gaze palsy (HP:0000605) | 1.94456398 |
| 140 | Bilateral microphthalmos (HP:0007633) | 1.94057484 |
| 141 | Hypothermia (HP:0002045) | 1.92436521 |
| 142 | Pallor (HP:0000980) | 1.92329387 |
| 143 | Vasculitis (HP:0002633) | 1.91215559 |
| 144 | Poor head control (HP:0002421) | 1.91156397 |
| 145 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.91053476 |
| 146 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90986913 |
| 147 | Sparse eyelashes (HP:0000653) | 1.90730012 |
| 148 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90565546 |
| 149 | Distal lower limb amyotrophy (HP:0008944) | 1.89980517 |
| 150 | Elevated alkaline phosphatase (HP:0003155) | 1.89949459 |
| 151 | Ectopic kidney (HP:0000086) | 1.89904531 |
| 152 | True hermaphroditism (HP:0010459) | 1.89617497 |
| 153 | Pendular nystagmus (HP:0012043) | 1.89585385 |
| 154 | Lymphopenia (HP:0001888) | 1.87480972 |
| 155 | Polygenic inheritance (HP:0010982) | 1.87460793 |
| 156 | Increased muscle lipid content (HP:0009058) | 1.86992497 |
| 157 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.86878183 |
| 158 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.86392562 |
| 159 | 11 pairs of ribs (HP:0000878) | 1.86339952 |
| 160 | Stridor (HP:0010307) | 1.85087407 |
| 161 | Oral leukoplakia (HP:0002745) | 1.84864238 |
| 162 | Hemorrhage of the eye (HP:0011885) | 1.84103346 |
| 163 | Abnormality of the duodenum (HP:0002246) | 1.83172040 |
| 164 | Abnormality of the nasal mucosa (HP:0000433) | 1.81681776 |
| 165 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81598011 |
| 166 | Interstitial pulmonary disease (HP:0006530) | 1.79934979 |
| 167 | Gastrointestinal dysmotility (HP:0002579) | 1.78983386 |
| 168 | Abnormality of the motor neurons (HP:0002450) | 1.78600350 |
| 169 | Abnormal neuron morphology (HP:0012757) | 1.78600350 |
| 170 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.78501177 |
| 171 | Sloping forehead (HP:0000340) | 1.76557123 |
| 172 | Abnormal trabecular bone morphology (HP:0100671) | 1.76059221 |
| 173 | Cheilitis (HP:0100825) | 1.74967898 |
| 174 | Long palpebral fissure (HP:0000637) | 1.74852230 |
| 175 | Trismus (HP:0000211) | 1.73864456 |
| 176 | Pathologic fracture (HP:0002756) | 1.73860034 |
| 177 | Granulocytopenia (HP:0001913) | 1.73801723 |
| 178 | Premature ovarian failure (HP:0008209) | 1.73688841 |
| 179 | Exertional dyspnea (HP:0002875) | 1.73537436 |
| 180 | Colitis (HP:0002583) | 1.73225311 |
| 181 | Anencephaly (HP:0002323) | 1.73204917 |
| 182 | Myopathic facies (HP:0002058) | 1.72607865 |
| 183 | Broad face (HP:0000283) | 1.72591078 |
| 184 | Horseshoe kidney (HP:0000085) | 1.72304900 |
| 185 | Short middle phalanx of the 5th finger (HP:0004220) | 1.72102459 |
| 186 | Selective tooth agenesis (HP:0001592) | 1.71651714 |
| 187 | Pancreatic fibrosis (HP:0100732) | 1.71269738 |
| 188 | Pancytopenia (HP:0001876) | 1.69761165 |
| 189 | Abnormal number of incisors (HP:0011064) | 1.69434436 |
| 190 | Increased serum lactate (HP:0002151) | 1.68858363 |
| 191 | Severe visual impairment (HP:0001141) | 1.68598185 |
| 192 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.68460782 |
| 193 | Pancreatic cysts (HP:0001737) | 1.67870412 |
| 194 | Progressive external ophthalmoplegia (HP:0000590) | 1.67142373 |
| 195 | Testicular atrophy (HP:0000029) | 1.65324252 |
| 196 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.63719194 |
| 197 | Facial cleft (HP:0002006) | 1.62110548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.81263804 |
| 2 | ERN1 | 3.64558914 |
| 3 | MKNK2 | 3.27834503 |
| 4 | SRPK1 | 2.94720934 |
| 5 | MKNK1 | 2.90044319 |
| 6 | MAP4K1 | 2.83197382 |
| 7 | WEE1 | 2.74700622 |
| 8 | TESK1 | 2.73066031 |
| 9 | AKT3 | 2.72119973 |
| 10 | NME2 | 2.46662440 |
| 11 | TRIB3 | 2.45936530 |
| 12 | TAOK2 | 2.39589417 |
| 13 | PLK4 | 2.38987262 |
| 14 | IRAK3 | 2.35582248 |
| 15 | CASK | 2.29607162 |
| 16 | STK16 | 2.27880450 |
| 17 | SMG1 | 2.14878140 |
| 18 | TBK1 | 2.12009749 |
| 19 | PRPF4B | 2.11745707 |
| 20 | PIM2 | 2.03971337 |
| 21 | IRAK4 | 2.02644369 |
| 22 | TLK1 | 1.99324995 |
| 23 | EIF2AK1 | 1.98356530 |
| 24 | KDR | 1.93532484 |
| 25 | ZAK | 1.92038704 |
| 26 | TSSK6 | 1.80513213 |
| 27 | YES1 | 1.71838228 |
| 28 | VRK1 | 1.68611079 |
| 29 | MAP2K3 | 1.67551537 |
| 30 | SIK1 | 1.66899416 |
| 31 | EIF2AK2 | 1.62381985 |
| 32 | PLK1 | 1.62094227 |
| 33 | CDK7 | 1.55722655 |
| 34 | TAOK1 | 1.54960718 |
| 35 | BCKDK | 1.49299442 |
| 36 | RIPK4 | 1.49106581 |
| 37 | VRK2 | 1.48806631 |
| 38 | ARAF | 1.46999689 |
| 39 | PIM1 | 1.39399419 |
| 40 | ICK | 1.38217820 |
| 41 | EPHB1 | 1.36601023 |
| 42 | EPHA2 | 1.35476322 |
| 43 | TYK2 | 1.34164646 |
| 44 | CLK1 | 1.33721944 |
| 45 | ACVR1B | 1.31951612 |
| 46 | BRSK2 | 1.31444434 |
| 47 | TTK | 1.30580531 |
| 48 | EIF2AK3 | 1.25989284 |
| 49 | LIMK1 | 1.23371282 |
| 50 | BLK | 1.23204721 |
| 51 | CHEK2 | 1.20539576 |
| 52 | IKBKB | 1.19421759 |
| 53 | SIK2 | 1.18397831 |
| 54 | PRKD3 | 1.13634160 |
| 55 | AURKA | 1.13349622 |
| 56 | DYRK3 | 1.12751769 |
| 57 | ADRBK2 | 1.12191289 |
| 58 | PRKD2 | 1.11841327 |
| 59 | PLK3 | 1.11799170 |
| 60 | CDK12 | 1.09950496 |
| 61 | TNK2 | 1.08313415 |
| 62 | TESK2 | 1.08040339 |
| 63 | CSK | 1.03885283 |
| 64 | ZAP70 | 1.03413020 |
| 65 | CDC7 | 1.02029692 |
| 66 | BMPR2 | 1.01544668 |
| 67 | MAP3K3 | 1.01480555 |
| 68 | TNIK | 1.00142169 |
| 69 | MAP3K1 | 0.99537453 |
| 70 | NEK2 | 0.97883625 |
| 71 | GRK5 | 0.97088554 |
| 72 | BRSK1 | 0.96097424 |
| 73 | DYRK2 | 0.94557195 |
| 74 | CDK8 | 0.94534645 |
| 75 | MATK | 0.94077919 |
| 76 | ABL2 | 0.93989845 |
| 77 | NLK | 0.93851544 |
| 78 | MAP3K14 | 0.93396394 |
| 79 | MUSK | 0.92517848 |
| 80 | STK38L | 0.92361415 |
| 81 | ATR | 0.90860103 |
| 82 | GRK7 | 0.90774648 |
| 83 | ERBB3 | 0.88454464 |
| 84 | RPS6KB2 | 0.88397698 |
| 85 | BRAF | 0.85349569 |
| 86 | CHUK | 0.83809989 |
| 87 | MAP3K13 | 0.83267051 |
| 88 | FES | 0.82777731 |
| 89 | AURKB | 0.82706259 |
| 90 | TXK | 0.82113493 |
| 91 | GRK6 | 0.81320295 |
| 92 | PTK6 | 0.81045481 |
| 93 | LMTK2 | 0.78398020 |
| 94 | GRK1 | 0.75237141 |
| 95 | MARK2 | 0.75096362 |
| 96 | MAP3K11 | 0.74756893 |
| 97 | RIPK1 | 0.74710986 |
| 98 | STK4 | 0.74421833 |
| 99 | DYRK1B | 0.73511833 |
| 100 | SIK3 | 0.72357880 |
| 101 | CDC42BPA | 0.71029817 |
| 102 | LRRK2 | 0.68936930 |
| 103 | EPHB2 | 0.68191920 |
| 104 | IRAK2 | 0.68067572 |
| 105 | RPS6KA2 | 0.67718196 |
| 106 | SCYL2 | 0.66621567 |
| 107 | CSNK2A1 | 0.65908390 |
| 108 | BMX | 0.65732095 |
| 109 | MAP3K8 | 0.65230609 |
| 110 | EEF2K | 0.64965261 |
| 111 | PRKCI | 0.64673813 |
| 112 | BRD4 | 0.63571266 |
| 113 | SYK | 0.61431385 |
| 114 | MST1R | 0.61346933 |
| 115 | DAPK1 | 0.60258061 |
| 116 | CSF1R | 0.60126648 |
| 117 | DAPK3 | 0.60038895 |
| 118 | MAPK13 | 0.59123612 |
| 119 | MAP2K7 | 0.58983517 |
| 120 | MAP3K5 | 0.58583703 |
| 121 | IKBKE | 0.57913429 |
| 122 | STK10 | 0.57692921 |
| 123 | MAP2K2 | 0.57003453 |
| 124 | RPS6KA4 | 0.56060488 |
| 125 | MAP3K12 | 0.53828523 |
| 126 | PDPK1 | 0.53651951 |
| 127 | FGR | 0.53491775 |
| 128 | KSR2 | 0.53000256 |
| 129 | HCK | 0.52268901 |
| 130 | CCNB1 | 0.51546735 |
| 131 | RPS6KC1 | 0.51094549 |
| 132 | RPS6KL1 | 0.51094549 |
| 133 | SGK2 | 0.50450433 |
| 134 | PKN2 | 0.49091062 |
| 135 | MAPK11 | 0.48733448 |
| 136 | CHEK1 | 0.48488545 |
| 137 | TEC | 0.47815480 |
| 138 | DDR2 | 0.47791502 |
| 139 | PAK1 | 0.47203530 |
| 140 | IRAK1 | 0.47044807 |
| 141 | LCK | 0.46232008 |
| 142 | RPS6KA6 | 0.45495667 |
| 143 | HIPK2 | 0.45183683 |
| 144 | STK24 | 0.44519210 |
| 145 | CDK2 | 0.43976582 |
| 146 | CSNK1G3 | 0.42225053 |
| 147 | CSNK2A2 | 0.41881026 |
| 148 | PRKG2 | 0.41864999 |
| 149 | MOS | 0.41453810 |
| 150 | MAPKAPK3 | 0.40687256 |
| 151 | CDK4 | 0.40523835 |
| 152 | CDK14 | 0.39791261 |
| 153 | MAPK12 | 0.39544809 |
| 154 | JAK3 | 0.39420207 |
| 155 | MAP3K6 | 0.39232016 |
| 156 | KIT | 0.38812911 |
| 157 | MAPKAPK2 | 0.38138085 |
| 158 | BTK | 0.38008870 |
| 159 | NEK9 | 0.36519600 |
| 160 | PAK4 | 0.35065181 |
| 161 | LYN | 0.34738216 |
| 162 | CDK19 | 0.33603711 |
| 163 | FLT3 | 0.33351956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.04788412 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 3.48287146 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.34417986 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.31903434 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.31554100 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.20554575 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 3.11106240 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.94104804 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.74437823 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.40213945 |
| 11 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.37619526 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.36660421 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22347968 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 2.20534675 |
| 15 | Basal transcription factors_Homo sapiens_hsa03022 | 2.17326608 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 2.15781837 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.10065038 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.06611673 |
| 19 | Cell cycle_Homo sapiens_hsa04110 | 2.05547768 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.02293708 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 2.00853544 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.82198829 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67728165 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.65372013 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.63015486 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55067882 |
| 27 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.54741882 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.54033787 |
| 29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.50408388 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47533170 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.45443939 |
| 32 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.40915830 |
| 33 | Purine metabolism_Homo sapiens_hsa00230 | 1.38373301 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37552019 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.37001735 |
| 36 | Bladder cancer_Homo sapiens_hsa05219 | 1.35700311 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.31848703 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31743387 |
| 39 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.30909528 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28513171 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.24576204 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21378576 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14438596 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14150699 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11831266 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.11028427 |
| 47 | Endocytosis_Homo sapiens_hsa04144 | 1.10710882 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08142167 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.06090480 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04469923 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01305149 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00899017 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00186668 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99350338 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 0.94959955 |
| 56 | Protein export_Homo sapiens_hsa03060 | 0.94159663 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93641805 |
| 58 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91533148 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90143329 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89033826 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88463957 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87935255 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87311187 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87175006 |
| 65 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.83438204 |
| 66 | Measles_Homo sapiens_hsa05162 | 0.83276014 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81533148 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80645883 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.80093803 |
| 70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.79945835 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.79928168 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78926077 |
| 73 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77991602 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77509505 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77378069 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76109580 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.75861441 |
| 78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.74849011 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71904791 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71505107 |
| 81 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.71098372 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70430972 |
| 83 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67330648 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66907063 |
| 85 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66709992 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66339618 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65645686 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64974428 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63320495 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61629659 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61210949 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60854114 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60770915 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59838448 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59772534 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58444952 |
| 97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57767178 |
| 98 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55606758 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.55514149 |
| 100 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54756830 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54575097 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54384354 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53837900 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53527242 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52434313 |
| 106 | Shigellosis_Homo sapiens_hsa05131 | 0.52369717 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.51857732 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51631684 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.51504990 |
| 110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51071121 |
| 111 | Influenza A_Homo sapiens_hsa05164 | 0.47453648 |
| 112 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45999551 |
| 113 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45210932 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45126290 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.45043062 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44878027 |
| 117 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44474551 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43653566 |
| 119 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42153183 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41287098 |
| 121 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40116778 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.39987711 |
| 123 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38419798 |
| 124 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.34808970 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33799651 |
| 126 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.33379206 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32193689 |
| 128 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31808286 |
| 129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31499690 |
| 130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.29531760 |
| 131 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28979023 |
| 132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28555994 |
| 133 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.27989562 |
| 134 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.27461134 |
| 135 | Phototransduction_Homo sapiens_hsa04744 | 0.27193787 |
| 136 | Pathways in cancer_Homo sapiens_hsa05200 | 0.26433047 |
| 137 | Alzheimers disease_Homo sapiens_hsa05010 | 0.25060366 |
| 138 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.24646886 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24517760 |
| 140 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.24174934 |
| 141 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23830740 |
| 142 | Colorectal cancer_Homo sapiens_hsa05210 | 0.23547952 |
| 143 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22742658 |
| 144 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22243462 |
| 145 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18561905 |
| 146 | Pertussis_Homo sapiens_hsa05133 | 0.17954245 |

